BILL NUMBER: A9407
PURPOSE OR GENERAL IDEA OF BILL:
To prohibit prior authorization for oncology care which has previously been authorized and complies with National Comprehensive Cancer Network (NCCN) guidelines with Categories of Evidence and Consensus 1 or
2A as evidence-based standards of care.
Proud of the New York State Assembly for introducing this bill which bans #priorAuth for any cancer rx w/ a NCCN level 1 or 2A rec. This would be a meaningful step to #FixPriorAuth. 💊 ☢️
#PriorAuthorization: "it's just wasting people's time"
nyassembly.gov/leg/?default...
@ascocancer.bsky.social